Texas Yale Capital Corp’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,000
Closed -$234K 476
2021
Q4
$234K Hold
4,000
0.01% 410
2021
Q3
$237K Hold
4,000
0.01% 408
2021
Q2
$347K Hold
4,000
0.02% 359
2021
Q1
$330K Hold
4,000
0.02% 355
2020
Q4
$364K Buy
+4,000
New +$364K 0.02% 343